- Respimat Delivers
RESPIMAT® Is Designed for Improved Drug Delivery1–5
- Lung deposition: The mist is comprised of highly respirable, small particle-sized droplets4,5
- Inhalation effort: Unlike dry powder inhalers, RESPIMAT operates independent of inspiratory effort to help get medication deep into patients’ lungs1,3
- Coordination: RESPIMAT may help facilitate actuation and inhalation4,5
As with all inhaled drugs, the actual amount of drug delivered to the lung may depend on patient factors, such as the coordination between the actuation of the inhaler and inspiration through the delivery system. The duration of inspiration should be at least as long as the spray duration (1.5 seconds).6View lung deposition data for RESPIMAT for Asthma
See the RESPIMAT Inhaler in action
You and your patients can watch this video to learn more about the RESPIMAT mist.Watch video
RESPIMAT delivers medication efficiently and effectively to the lungs and helps reduce oropharyngeal deposition1–5
There is no correlation between deposition data and clinical efficacy. Active ingredients used in the studies are not commercially available in RESPIMAT. The specific physical–chemical characteristics of the drug may affect lung deposition.
*Data were collected from asthma patients. The images above are typical scintographic pictures, taken from a study patient, comparing drug deposition profiles. The percentage of dose deposition is the mean of 14 asthma study patients. Analysis of deposition in central, intermediate, and peripheral lung regions showed that deposition occurred in all 3 regions but was concentrated in the central lung region for Turbuhaler® to a greater extent than for RESPIMAT and Becloforte® (pressurized metered-dose inhaler [pMDI]). This was reflected in significantly (p<0.01) higher mean peripheral zone/central zone deposition ratios for RESPIMAT (1.34) and Becloforte (1.27) than for Turbuhaler with fast flow (0.95) or Turbuhaler with slow flow (0.82). The publisher for the copyrighted material is Mary Ann Liebert, Inc. publishers.2
All trademarks are the property of their respective owners.
- How to use
Helping Your Patients Use SPIRIVA RESPIMAT
- Preparing the Inhaler
for First-Time Use
Remove clear base
- Keep the cap closed.
- Press the safety catch while firmly pulling off the clear base with your other hand. Be careful not to touch the piercing element.
- Write the discard by date on the label (3 months from the date the cartridge is inserted).
- Insert the narrow end of the cartridge into the inhaler.
- Place the inhaler on a firm surface and push down firmly until it clicks into place.
Replace clear base
- Put the clear base back into place until it clicks.
- Do not remove the clear base or the cartridge after it has been put together.
- Keep the cap closed.
- Turn the clear base in the direction of the arrows on the label until it clicks (half a turn).
- Open the cap until it snaps fully open.
- Point the inhaler toward the ground.
- Press the dose-release button.
- Close the cap.
- If you do not see a mist, repeat steps 4 to 6 until a mist is seen.
- After a mist is seen, repeat steps 4–6 three more times.
- After complete preparation of your inhaler, it will be ready to deliver the number of puffs on the label.
- Remove clear base
3 steps for daily use
After preparing the device, patients can remember the steps for daily use with T.O.P.6 These steps must be repeated 2 times, once‑daily, to receive the full dose of medication.
- Keep the cap closed
- Turn the clear base in the direction of the arrows on the label until it clicks (half a turn)
- Open the cap until it snaps fully open
- Breathe out slowly and fully
- Close your lips around the mouthpiece without covering the air vents
- Point the inhaler to the back of your throat
- While taking a slow, deep breath through your mouth, Press the dose-release button and continue to breathe in
- Hold your breath for 10 seconds or for as long as comfortable
- Repeat Turn, Open, Press (TOP) for a total of 2 puffs
- Close the cap until you use your inhaler again
With SPIRIVA RESPIMAT,
remember to tell your patients
1 DOSE = 2 PUFFS ONCE DAILY6
In the treatment of asthma, the maximum benefits in lung function may take up to 4 to 8 weeks of dosing.
Children should use SPIRIVA RESPIMAT with the help of an adult, as instructed by their physician.
For detailed instructions, patients should refer to the Instructions for Use enclosed with their prescription.
Note: SPIRIVA RESPIMAT should not be sprayed in the eyes as this may cause blurred vision and pupil dilation.
This dose indicator shows approximately how much medicine is left. When the dose indicator enters the red area of the scale, a refill is required; there is enough medicine for 7 days left (if your patient has a sample, there is enough medicine for 3 days left).6
Do Your Patients Need More Help Using SPIRIVA RESPIMAT?
For live support, patients can call Solutions Plus at 1-888-784-5415 Monday-Friday 8AM-8PM ET
- Preparing the Inhaler